| Dr John P Waytuk, DO | |
|
450 S Ocotillo Ave, Benson, AZ 85602-6403 | |
| (520) 586-2261 | |
| Not Available |
| Full Name | Dr John P Waytuk |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 41 Years |
| Location | 450 S Ocotillo Ave, Benson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205985561 | NPI | - | NPPES |
| 150102 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2855 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Copper Queen Community Hospital | Bisbee, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bisbee Hospital Association | 5092626168 | 41 |
News Archive
According to a recent Leger Marketing poll, 14 per cent of Canadians believe women can be diagnosed with prostate cancer, and an additional 20 per cent aren't sure. Only 56 per cent know with certainty that men are the only ones who can be afflicted.
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test.
Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a unique UK trial.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
› Verified 7 days ago
| Entity Name | Dhew Ind Hlth Sv Hlth Svs & Mntl Hlth Adm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083643738 PECOS PAC ID: 1759290901 Enrollment ID: O20031105000797 |
News Archive
According to a recent Leger Marketing poll, 14 per cent of Canadians believe women can be diagnosed with prostate cancer, and an additional 20 per cent aren't sure. Only 56 per cent know with certainty that men are the only ones who can be afflicted.
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test.
Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a unique UK trial.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John P Waytuk, DO 4119 E Sells Dr, Phoenix, AZ 85018-4253 Ph: (602) 430-8910 | Dr John P Waytuk, DO 450 S Ocotillo Ave, Benson, AZ 85602-6403 Ph: (520) 586-2261 |
News Archive
According to a recent Leger Marketing poll, 14 per cent of Canadians believe women can be diagnosed with prostate cancer, and an additional 20 per cent aren't sure. Only 56 per cent know with certainty that men are the only ones who can be afflicted.
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test.
Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a unique UK trial.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
› Verified 7 days ago
Dr. Kalpana R. Pandit, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 450 S Ocotillo Ave, Benson, AZ 85602 Phone: 520-586-2261 | |
Dr. Joseph G Rizza, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 450 S Ocotillo Ave, Benson, AZ 85602 Phone: 520-586-2261 Fax: 520-586-2265 | |
Dr. Cherie Alta Thomas, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 890 W 4th St, Benson, AZ 85602 Phone: 520-586-3664 Fax: 520-586-3486 |